Efficacy and Safety of Artiss Fibrin Tissue Sealant Use in Rhytidectomy: A Review of 120 Cases

Abstract

Hematoma formation has persisted as the most common complication in rhytidectomy. The objective of this study is to determine the efficacy and safety of Artiss (Baxter) for use in rhytidectomies. In addition, we determine the use of fibrin tissue sealants by facial plastic surgeons. In this retrospective chart review, 120 patients in a single private practice were identified who underwent a rhytidectomy from August 2013 to January 2015 by a single facial plastic surgeon. The last 60 rhytidectomies performed with Tisseel (Baxter) were compared with the first 60 rhytidectomies performed with Artiss.

All perioperative or postoperative complications were identified and recorded, focusing on the incidence of hematoma. In addition, a six-question survey was created and sent to all members of the American Academy of Facial Plastic and Reconstructive Surgery. Results of the survey were recorded and analyzed for trends or patterns in the data. In total, 120 patients were assessed. In the Tisseel group, two complications of fluid collection requiring needle aspiration were recorded. No other complications were found. In the Artiss group, 10 complications were recorded, including 9 fluid collections requiring needle aspiration and 1 hematoma. In total, 179 members of the American Academy of Facial Plastic and Reconstructive Surgery completed the six-question survey. Of all respondents, 61 (34%) use tissue sealants for rhytidectomies, whereas 118 (66%) do not. Artiss is efficacious and safe for use in rhytidectomies. Its use obviates the need for surgical drains, and complications are minimal and similar in rate to the use of Tisseel.

Keywords

facelift - Artiss - hematoma - fibrin - Tisseel

• References

• 1 Kleinberger AJ, Spiegel JH. What is the best method for minimizing the risk of hematoma formation after rhytidectomy?. Laryngoscope 2015; 125 (03) 534-536
• 2 Flemming I. Fibrin glue in face lifts. Facial Plast Surg 1992; 8 (01) 79-88
• 3 Matras H, Dinges HP, Lassmann H, Mamoli B. Suture-free interfascicular nerve transplantation in animal experiments [in German]. Wien Med Wochenschr 1972; 122 (37) 517-523
• 4 Bruck HG. Fibrin tissue adhesion and its use in rhytidectomy: a pilot study. Aesthetic Plast Surg 1982; 6 (04) 197-202
• 5 Oliver DW, Hamilton SA, Figle AA, Wood SH, Lamberty BG. A prospective, randomized, double-blind trial of the use of fibrin sealant for face lifts. Plast Reconstr Surg 2001; 108 (07) 2101-2105 , discussion 2106–2107
• 6 Marchac D, Greensmith AL. Early postoperative efficacy of fibrin glue in face lifts: a prospective randomized trial. Plast Reconstr Surg 2005; 115 (03) 911-916 , discussion 917–918
• 7 Kamer FM, Nguyen DB. Experience with fibrin glue in rhytidectomy. Plast Reconstr Surg 2007; 120 (04) 1045-1051 , discussion 1052
• 8 Lee S, Pham AM, Pryor SG, Tollefson T, Sykes JM. Efficacy of Crosseal fibrin sealant (human) in rhytidectomy. Arch Facial Plast Surg 2009; 11 (01) 29-33
• 9 Zoumalan R, Rizk SS. Hematoma rates in drainless deep-plane face-lift surgery with and without the use of fibrin glue. Arch Facial Plast Surg 2008; 10 (02) 103-107
• 10 Por YC, Shi L, Samuel M, Song C, Yeow VK. Use of tissue sealants in face-lifts: a metaanalysis. Aesthetic Plast Surg 2009; 33 (03) 336-339
• 11 Spotnitz WD. Efficacy and safety of fibrin sealant for tissue adherence in facial rhytidectomy. Clin Cosmet Investig Dermatol 2012; 5: 43-51
• 12 Mustoe TA, Park E. Evidence-based medicine: Face lift. Plast Reconstr Surg 2014; 133 (05) 1206-1213
• 13 Baxter International Inc. History. http://www.baxter.com/about_baxter/company_profile/history.html#1990 . Accessed March 30, 2015
• 14 Baxter International Inc. Baxter Announces FDA Approval of ARTISS Fibrin Sealant For Use in Face-Lift (Facial Rhytidectomy) Procedures. http://www.baxter.com/press_room/press_releases/2011/08_31_11_artiss.html . Accessed March 30, 2015
• 15 Hester Jr TRJ, Shire JR, Nguyen DB. , et al. Randomized, controlled, phase 3 study to evaluate the safety and efficacy of fibrin sealant VH S/D 4 s-apr (Artiss) to improve tissue adherence in subjects undergoing rhytidectomy. Aesthet Surg J 2013; 33 (04) 487-496
• 16 Neto JC, Rodriguez Fernandez DE, Boles M. Reducing the incidence of hematomas in cervicofacial rhytidectomy: new external quilting sutures and other ancillary procedures. Aesthetic Plast Surg 2013; 37 (05) 1034-1039
• 17 Perkins SW, Williams JD, Macdonald K, Robinson EB. Prevention of seromas and hematomas after face-lift surgery with the use of postoperative vacuum drains. Arch Otolaryngol Head Neck Surg 1997; 123 (07) 743-745
• 18 Jones BM, Grover R, Hamilton S. The efficacy of surgical drainage in cervicofacial rhytidectomy: a prospective, randomized, controlled trial. Plast Reconstr Surg 2007; 120 (01) 263-270
• 19 Jones BM, Grover R. Avoiding hematoma in cervicofacial rhytidectomy: a personal 8-year quest. Reviewing 910 patients. Plast Reconstr Surg 2004; 113 (01) 381-387, discussion 388–390
• 20 Fezza JP, Cartwright M, Mack W, Flaharty P. The use of aerosolized fibrin glue in face-lift surgery. Plast Reconstr Surg 2002; 110 (02) 658-664 , discussion 665–666
• 21 Pathogen Safety Monograph. Available at www.floseal.jp/resources/pdfs/BS1952%20Pathogen_Safety_Mono_SOP_APPROVED032709.pdf
• 22 Regan FA, Hewitt P, Barbara JA, Contreras M. ; TTI Study Group. Prospective investigation of transfusion transmitted infection in recipients of over 20 000 units of blood. BMJ 2000; 320 (7232): 403-406